Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Invested Capital (2020 - 2025)

Historic Invested Capital for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $92.7 million.

  • Pulse Biosciences' Invested Capital rose 1713.99% to $92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.7 million, marking a year-over-year increase of 1713.99%. This contributed to the annual value of $114.9 million for FY2024, which is 15893.15% up from last year.
  • Latest data reveals that Pulse Biosciences reported Invested Capital of $92.7 million as of Q3 2025, which was up 1713.99% from $104.5 million recorded in Q2 2025.
  • Pulse Biosciences' 5-year Invested Capital high stood at $118.5 million for Q1 2025, and its period low was -$10.7 million during Q1 2023.
  • Over the past 5 years, Pulse Biosciences' median Invested Capital value was $44.4 million (recorded in 2021), while the average stood at $49.4 million.
  • The largest annual percentage gain for Pulse Biosciences' Invested Capital in the last 5 years was 207330.96% (2023), contrasted with its biggest fall of 15129.83% (2023).
  • Over the past 5 years, Pulse Biosciences' Invested Capital (Quarter) stood at $44.4 million in 2021, then plummeted by 105.07% to -$2.2 million in 2022, then soared by 2073.31% to $44.4 million in 2023, then skyrocketed by 158.93% to $114.9 million in 2024, then decreased by 19.3% to $92.7 million in 2025.
  • Its Invested Capital was $92.7 million in Q3 2025, compared to $104.5 million in Q2 2025 and $118.5 million in Q1 2025.